| A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023 | 1066 | 2023 |
| Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives JP Arab, SJ Karpen, PA Dawson, M Arrese, M Trauner Hepatology 65 (1), 350-362, 2017 | 578 | 2017 |
| Recent insights into the pathogenesis of nonalcoholic fatty liver disease JP Arab, M Arrese, M Trauner Annual Review of Pathology: Mechanisms of Disease 13, 321-350, 2018 | 541 | 2018 |
| Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022 | 428 | 2022 |
| Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19 AV Kulkarni, P Kumar, HV Tevethia, M Premkumar, JP Arab, R Candia, ... Alimentary pharmacology & therapeutics 52 (4), 584-599, 2020 | 265 | 2020 |
| Global burden of liver disease: 2023 update H Devarbhavi, SK Asrani, JP Arab, YA Nartey, E Pose, PS Kamath Journal of hepatology 79 (2), 516-537, 2023 | 239 | 2023 |
| Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg JP Arab, RM Martin-Mateos, VH Shah Hepatology international 12, 24-33, 2018 | 203 | 2018 |
| Mechanical stretch increases expression of CXCL1 in liver sinusoidal endothelial cells to recruit neutrophils, generate sinusoidal microthombi, and promote portal hypertension MB Hilscher, T Sehrawat, JP Arab, Z Zeng, J Gao, M Liu, E Kostallari, ... Gastroenterology 157 (1), 193-209. e9, 2019 | 167 | 2019 |
| Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis J Argemi, MU Latasa, SR Atkinson, IO Blokhin, V Massey, JP Gue, ... Nature communications 10 (1), 3126, 2019 | 153 | 2019 |
| An open‐label, dose‐escalation study to assess the safety and efficacy of IL‐22 agonist F‐652 in patients with alcohol‐associated hepatitis JP Arab, TS Sehrawat, DA Simonetto, VK Verma, D Feng, T Tang, ... Hepatology 72 (2), 441-453, 2020 | 126 | 2020 |
| The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease N Mendez-Sanchez, M Arrese, A Gadano, CP Oliveira, E Fassio, JP Arab, ... The Lancet Gastroenterology & Hepatology 6 (1), 65-72, 2021 | 109 | 2021 |
| Liver dysfunction as a novel player in Alzheimer’s progression: looking outside the brain LD Estrada, P Ahumada, D Cabrera, JP Arab Frontiers in aging neuroscience 11, 174, 2019 | 106 | 2019 |
| Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities F Idalsoaga, AV Kulkarni, OY Mousa, M Arrese, JP Arab Frontiers in medicine 7, 448, 2020 | 98 | 2020 |
| Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH) JP Arab, JP Roblero, J Altamirano, F Bessone, RC Araujo, ... Annals of hepatology 18 (3), 518-535, 2019 | 93 | 2019 |
| Management of nonalcoholic fatty liver disease: an evidence-based clinical practice review JP Arab, R Candia, R Zapata, C Muñoz, JP Arancibia, J Poniachik, ... World Journal of Gastroenterology: WJG 20 (34), 12182, 2014 | 91 | 2014 |
| Reducing the global burden of alcohol‐associated liver disease: a blueprint for action SK Asrani, J Mellinger, JP Arab, VH Shah Hepatology 73 (5), 2039-2050, 2021 | 86 | 2021 |
| Use of statins in patients with chronic liver disease and cirrhosis: current views and prospects JI Vargas, M Arrese, VH Shah, JP Arab Current gastroenterology reports 19, 1-10, 2017 | 85 | 2017 |
| Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs RC Huebert, K Jagavelu, HI Hendrickson, MM Vasdev, JP Arab, ... The American journal of pathology 179 (4), 1851-1860, 2011 | 84 | 2011 |
| UDCA, NorUDCA, and TUDCA in liver diseases: a review of their mechanisms of action and clinical applications D Cabrera, JP Arab, M Arrese Bile Acids and Their Receptors, 237-264, 2019 | 81 | 2019 |
| Andrographolide ameliorates inflammation and fibrogenesis and attenuates inflammasome activation in experimental non-alcoholic steatohepatitis D Cabrera, A Wree, D Povero, N Solís, A Hernandez, M Pizarro, ... Scientific reports 7 (1), 3491, 2017 | 81 | 2017 |
Luis Antonio Diaz P.Pontificia Universidad Católica de ChileVerified email at uc.cl
